Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT05209074
Title Ivosidenib + mFOLFIRINOX in Patients With Resectable Pancreatic Adenocarcinoma
Recruitment Not yet recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Case Comprehensive Cancer Center

pancreatic adenosquamous carcinoma

pancreatic adenocarcinoma


Fluorouracil + Irinotecan + Ivosidenib + Leucovorin + Oxaliplatin

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.